Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease

There is a closely relationship between the development and progression of nonalcoholic fatty liver disease (NAFLD) or metabolic associated fatty liver disease (MAFLD) and obesity and diabetes. NAFLD fibrosis scores should be routinely used to rule out patients with advanced fibrosis. High scores ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Unsal, İlknur Ozturk, Calapkulu, Murat, Sencar, Muhammed Erkam, Cakal, Basak, Ozbek, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741957/
https://www.ncbi.nlm.nih.gov/pubmed/34997159
http://dx.doi.org/10.1038/s41598-021-04361-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741957/
https://www.ncbi.nlm.nih.gov/pubmed/34997159
http://dx.doi.org/10.1038/s41598-021-04361-x

Ejemplares similares